Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody von Segal, Neil H, Logan, Theodore F, Hodi, F Stephen, McDermott, David, Melero, Ignacio, Hamid, Omid, Schmidt, Henrik, Robert, Caroline, Chiarion-Sileni, Vanna, Ascierto, Paolo A, Maio, Michele, Urba, Walter J, Gangadhar, Tara C, Suryawanshi, Satyendra, Neely, Jaclyn, Jure-Kunkel, Maria, Krishnan, Suba, Kohrt, Holbrook, Sznol, Mario, Levy, Ronald

Volltext

Linking Tumor Growth Dynamics to Survival in Ipilimumab‐Treated Patients With Advanced Melanoma Using Mixture Tumor Growth Dynamic Modeling von Feng, Yan, Wang, Xiaoning, Suryawanshi, Satyendra, Bello, Akintunde, Roy, Amit

Volltext

Nivolumab exposure–response analysis for adjuvant treatment of melanoma supporting a change in posology von Sanghavi, Kinjal, Vuppala, Pradeep, Ivaturi, Vijay, Hamuro, Lora, Roy, Amit, Suryawanshi, Satyendra

Volltext

Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors von Khushalani, Nikhil I, Ott, Patrick A, Ferris, Robert L, Cascone, Tina, Schadendorf, Dirk, Le, Dung T, Sharma, Manish R, Barlesi, Fabrice, Sharfman, William, Luke, Jason J, Melero, Ignacio, Lathers, Deanne, Neely, Jaclyn, Suryawanshi, Satyendra, Sanyal, Abanti, Holloway, James L, Suryawanshi, Rasika, Ely, Scott, Segal, Neil H

Volltext

Preclinical Pharmacokinetic/Pharmacodynamic Modeling and Simulation in the Pharmaceutical Industry: An IQ Consortium Survey Examining the Current Landscape von Schuck, Edgar, Bohnert, Tonika, Chakravarty, Arijit, Damian-Iordache, Valeriu, Gibson, Christopher, Hsu, Cheng-Pang, Heimbach, Tycho, Krishnatry, Anu Shilpa, Liederer, Bianca M, Lin, Jing, Maurer, Tristan, Mettetal, Jerome T, Mudra, Daniel R, Nijsen, Marjoleen JMA, Raybon, Joseph, Schroeder, Patricia, Schuck, Virna, Suryawanshi, Satyendra, Su, Yaming, Trapa, Patrick, Tsai, Alice, Vakilynejad, Majid, Wang, Shining, Wong, Harvey

Volltext

Preclinical evaluation of SMM‐189, a cannabinoid receptor 2‐specific inverse agonist von Presley, Chaela, Abidi, Ammaar, Suryawanshi, Satyendra, Mustafa, Suni, Meibohm, Bernd, Moore, Bob M.

Volltext

Liquid chromatography/tandem mass spectrometric study and analysis of xanthone and secoiridoid glycoside composition of Swertia chirata, a potent antidiabetic von Suryawanshi, Satyendra, Mehrotra, Nitin, Asthana, R. K., Gupta, Ram C.

Volltext

Evaluation of covariate effects on pharmacokinetics of monoclonal antibodies in oncology von Bajaj, Gaurav, Suryawanshi, Satyendra, Roy, Amit, Gupta, Manish

Volltext

Pharmacokinetics and Clinical Pharmacology of Monoclonal Antibodies in Pediatric Patients von Temrikar, Zaid H., Suryawanshi, Satyendra, Meibohm, Bernd

Volltext

Simultaneous estimation of mangiferin and four secoiridoid glycosides in rat plasma using liquid chromatography tandem mass spectrometry and its application to pharmacokinetic stud... von Suryawanshi, Satyendra, Asthana, R.K., Gupta, R.C.

Volltext

Pediatric Rare Diseases Development in the Pharmaceutical Industry: An International Consortium for Innovation and Quality in Pharmaceutical Development, Clinical Pharmacology Lead... von Krishna, Rajesh, Sebastien, Bernard, Corriol‐Rohou, Solange, Cheung, S. Y. Amy, Liu, Jing, Suryawanshi, Satyendra

Volltext

Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVIT... von Ascierto, Paolo Antonio, Lipson, Evan J, Dummer, Reinhard, Larkin, James, Long, Georgina V, Sanborn, Rachel E, Chiarion-Sileni, Vanna, Dréno, Brigitte, Dalle, Stéphane, Schadendorf, Dirk, Callahan, Margaret K, Nyakas, Marta, Atkinson, Victoria, Gomez-Roca, Carlos Alberto, Yamazaki, Naoya, Tawbi, Hussein A, Sarkis, Naomey, Warad, Deepti, Dolfi, Sonia, Mitra, Priyam, Suryawanshi, Satyendra, Grob, Jean-Jacques

Volltext

Quantitative Extrapolation: An Approach to Validation of Adult Drug Efficacy in Pediatric Subjects von Leil, Tarek A., Zee, Pamela, Suryawanshi, Satyendra, Male, Christoph, Portman, Ronald

Volltext

Reporting, Visualization, and Modeling of Immunogenicity Data to Assess Its Impact on Pharmacokinetics, Efficacy, and Safety of Monoclonal Antibodies von Passey, Chaitali, Suryawanshi, Satyendra, Sanghavi, Kinjal, Gupta, Manish

Volltext

Urelumab alone or in combination with rituximab in patients with relapsed or refractory B‐cell lymphoma von Timmerman, John, Herbaux, Charles, Ribrag, Vincent, Zelenetz, Andrew D., Houot, Roch, Neelapu, Sattva S., Logan, Theodore, Lossos, Izidore S., Urba, Walter, Salles, Gilles, Ramchandren, Radhakrishnan, Jacobson, Caron, Godwin, John, Carpio, Cecilia, Lathers, Deanne, Liu, Yali, Neely, Jaclyn, Suryawanshi, Satyendra, Koguchi, Yoshinobu, Levy, Ronald

Volltext

First-Line Nivolumab and Relatlimab Plus Chemotherapy for Gastric or Gastroesophageal Junction Adenocarcinoma: The Phase II RELATIVITY-060 Study von Hegewisch-Becker, Susanna, Mendez, Guillermo, Chao, Joseph, Nemecek, Radim, Feeney, Kynan, Van Cutsem, Eric, Al-Batran, Salah-Eddin, Mansoor, Wasat, Maisey, Nicholas, Pazo Cid, Roberto, Burge, Matthew, Perez-Callejo, David, Hipkin, R. William, Mukherjee, Sourav, Lei, Ming, Tang, Hao, Suryawanshi, Satyendra, Kelly, Ronan J, Tebbutt, Niall C

Volltext

Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVIT... von Ascierto, Paolo Antonio, Lipson, Evan J, Dummer, Reinhard, Larkin, James, Long, Georgina V, Sanborn, Rachel E, Chiarion-Sileni, Vanna, Dréno, Brigitte, Dalle, Stéphane, Schadendorf, Dirk, Callahan, Margaret K, Nyakas, Marta, Atkinson, Victoria, Gomez-Roca, Carlos Alberto, Yamazaki, Naoya, Tawbi, Hussein A, Sarkis, Naomey, Warad, Deepti, Dolfi, Sonia, Mitra, Priyam, Suryawanshi, Satyendra, Grob, Jean-Jacques

Volltext

A sensitive and selective HPLC/ESI-MS/MS assay for the simultaneous quantification of 16-dehydropregnenolone and its major metabolites in rabbit plasma von Suryawanshi, Satyendra, Singh, S.K., Gupta, R.C.

Volltext

ATIM-19. POPULATION PHARMACOKINETIC (PPK) ANALYSIS OF NIVOLUMAB FLAT AND WEIGHT-BASED DOSING REGIMENS AND ASSOCIATIONS WITH SAFETY IN PATIENTS WITH RECURRENT GLIOBLASTOMA (rGBM) TR... von Shen, Jun, Hruska, Matthew, Zwirtes, Ricardo, Potter, Von, Paliwal, Prashni, Roy, Amit, Bello, Akintunde, Suryawanshi, Satyendra, Lim, Michael

Volltext

Translational pharmacokinetic-pharmacodynamic analysis in the pharmaceutical industry: an IQ Consortium PK-PD Discussion Group perspective von Wong, Harvey, Bohnert, Tonika, Damian-Iordache, Valeriu, Gibson, Christopher, Hsu, Cheng-Pang, Krishnatry, Anu Shilpa, Liederer, Bianca M., Lin, Jing, Lu, Qiang, Mettetal, Jerome T., Mudra, Daniel R., Nijsen, Marjoleen J.M.A., Schroeder, Patricia, Schuck, Edgar, Suryawanshi, Satyendra, Trapa, Patrick, Tsai, Alice, Wang, Haiqing, Wu, Fan

Volltext